Contraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study

Contraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study

Item
http://www.wikidata.org/entity/Q28384507
Adherence to a flexible extended regimen for oral hormonal contraception provided in blister packaging compared with an adherence-supporting digital tablet dispenser: historical comparison of data from two clinical studiesAdherence with ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-label, randomized, multicenter studyEfficacy and safety of a flexible extended regimen of ethinylestradiol/drospirenone for the treatment of dysmenorrhea: a multicenter, randomized, open-label, active-controlled studyDifferent Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.An update on new orally administered contraceptives for women.Long-term tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study.Characterisation of the pharmacokinetics of ethinylestradiol and drospirenone in extended-cycle regimens: population pharmacokinetic analysis from a randomised Phase III study.Continuous use of oral contraceptives: an overview of effects and side-effects.Evolution of extended use of the combined oral contraceptive pill.Extended regimens of combined hormonal contraception to reduce symptoms related to withdrawal bleeding and the hormone-free interval: a systematic review of randomised and observational studies.Expert opinion on a flexible extended regimen of drospirenone/ethinyl estradiol contraceptive.Advances in pharmacotherapy for treating endometriosis.Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone.
P2860

Contraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study

Item
http://www.wikidata.org/entity/Q28384507
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Contraceptive efficacy and tol ...... , randomised, controlled study
@ast
Contraceptive efficacy and tol ...... , randomised, controlled study
@en
Contraceptive efficacy and tol ...... , randomised, controlled study
@nl
type
label
Contraceptive efficacy and tol ...... , randomised, controlled study
@ast
Contraceptive efficacy and tol ...... , randomised, controlled study
@en
Contraceptive efficacy and tol ...... , randomised, controlled study
@nl
prefLabel
Contraceptive efficacy and tol ...... , randomised, controlled study
@ast
Contraceptive efficacy and tol ...... , randomised, controlled study
@en
Contraceptive efficacy and tol ...... , randomised, controlled study
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P3181
P356
P1433
P1476
Contraceptive efficacy and tol ...... , randomised, controlled study
@en
P2093
P2860
P304
P31
P3181
P356
10.1136/JFPRHC-2011-100213
P407
P433
P478
P577
P5875
P698
P921
P932